AstraZeneca COVID-19 vaccine study paused after one illness

In a statement issued Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data.”

from mint - News https://ift.tt/2ZjczMm
https://ift.tt/eA8V8J